Credibility
Clinical evidence comes first
Every technology we introduce to our portfolio is evaluated based on published clinical evidence. Market trends alone do not define our choices.
Values & Philosophy
Technologies shaping modern dermatology
Skin science is constantly evolving, and so are the technologies that support modern medical and aesthetic dermatology. Market trends change, but scientific and clinical evidence remain the foundation for informed technology selection.
INTEGRIS Pharma, through its specialized Medical and Aesthetic Dermatology Division Integris Derma, brings clinically documented photobiomodulation technologies to healthcare professionals in Greece and Cyprus. Each technology is selected according to rigorous scientific criteria, including its mechanism of action, clinical evidence, and the meaningful value it brings to everyday clinical practice.
Differentiation
The mechanism of action matters
We look for technologies supported by a clear scientific rationale, well-defined biological mechanisms and measurable biological or clinical responses.
Transparency
Regulatory compliance is non-negotiable
Every product in our portfolio is classified in full accordance with the applicable regulatory framework. Its regulatory classification, whether as a medical device or as a cosmetic, is determined exclusively by its intended purpose, ensuring compliance, transparency and safety.
Commitment
Continuous Clinical Support and Education
We provide clinical protocols, scientific resources, and ongoing professional education to help healthcare professionals integrate new technologies into everyday medical and aesthetic dermatology practice.
We select technologies that create lasting value for healthcare professionals and their patients.
